<p>(A) NT2/D1 cells were incubated with media containing 47 µM curcuminoids (SOLID+DMSO) for 5 h. Left panel: The elution profile at 310 nm wavelength of metabolites derived from BDMC (B*), DMC (D*), and CUR (C*) in the media. Center and right panels: The elution profiles at 427 nm wavelength of curcuminoids extracted from cells and media, respectively. The relative areas under the curve of each peak are indicated in square brackets. (B) Time course of the generation of curcuminoid metabolites (OD at 310 nm wavelength) in the media under three incubation conditions: Incubation of cells with 47 µM curcuminoids in 5% FCS (I, ▪), with 24 µM curcuminoids in 2.5% FCS (II, ○), or with 24 µM curcuminoids in 5% FCS (III, •). Insert: The value of th...
<p>(A) Binding dose curves with variable serum and curcuminoid concentrations in media containing FC...
<p><b>(A)</b><i>B</i>. <i>subtilis</i> AH75 strain was grown in LB media having spectinomycin antibi...
<p>MCF-7 cells were treated with either curcumin (10 µM) or Mitocur-1, 2, 3 (10 µM) respectively for...
<p>(A) CCF-STTG1 cells were incubated with media containing 47 µM curcuminoids (SOLID+DMSO) for 24 h...
<p>(A) Cells were incubated with media containing 27 µM starting concentrations (0 min) of curcumino...
<p>(A). Cells were incubated with media containing 47 µM curcuminoids (SOLID+DMSO) for 1 h. The medi...
<p>Left panel: SOLID-solubilized curcuminoids in FCS (SOLID). Center panel: DMSO-solubilized curcumi...
<p>(A) The effect of 0–5 µM curcuminoid starting concentrations in incubation media on cellular doub...
<p>(A) <i>In vitro</i> release study of native curcumin and curcumin-PLGA conjugate; a known quantit...
<p>(A) Phase contrast micrograph of NT2/D1 cells incubated with 47 µM media concentration of DMSO- s...
对有关姜黄素代谢研究的国内外文献进行了归纳和分析.姜黄素的血药浓度低,生物利用度不高;姜黄素在体内的生物转化包括还原,与葡萄糖醛酸结合.姜黄素的吸收机制﹑代谢物与生物活性的关系有待进一步阐明.中国抗癌...
<p>(A) Cells were either incubated with standard medium (•) or with medium containing 47 µM curcumin...
M3 was drawn according to the left zone of the mode in negative control group, which represented the...
<p>(A) Schematic outline of fractionation procedure. (B) Relative distribution of total curcuminoids...
<p>(A–C) Curcumin degradation at neutral pH (PBS) solution over time assessed by absorbance at 440 n...
<p>(A) Binding dose curves with variable serum and curcuminoid concentrations in media containing FC...
<p><b>(A)</b><i>B</i>. <i>subtilis</i> AH75 strain was grown in LB media having spectinomycin antibi...
<p>MCF-7 cells were treated with either curcumin (10 µM) or Mitocur-1, 2, 3 (10 µM) respectively for...
<p>(A) CCF-STTG1 cells were incubated with media containing 47 µM curcuminoids (SOLID+DMSO) for 24 h...
<p>(A) Cells were incubated with media containing 27 µM starting concentrations (0 min) of curcumino...
<p>(A). Cells were incubated with media containing 47 µM curcuminoids (SOLID+DMSO) for 1 h. The medi...
<p>Left panel: SOLID-solubilized curcuminoids in FCS (SOLID). Center panel: DMSO-solubilized curcumi...
<p>(A) The effect of 0–5 µM curcuminoid starting concentrations in incubation media on cellular doub...
<p>(A) <i>In vitro</i> release study of native curcumin and curcumin-PLGA conjugate; a known quantit...
<p>(A) Phase contrast micrograph of NT2/D1 cells incubated with 47 µM media concentration of DMSO- s...
对有关姜黄素代谢研究的国内外文献进行了归纳和分析.姜黄素的血药浓度低,生物利用度不高;姜黄素在体内的生物转化包括还原,与葡萄糖醛酸结合.姜黄素的吸收机制﹑代谢物与生物活性的关系有待进一步阐明.中国抗癌...
<p>(A) Cells were either incubated with standard medium (•) or with medium containing 47 µM curcumin...
M3 was drawn according to the left zone of the mode in negative control group, which represented the...
<p>(A) Schematic outline of fractionation procedure. (B) Relative distribution of total curcuminoids...
<p>(A–C) Curcumin degradation at neutral pH (PBS) solution over time assessed by absorbance at 440 n...
<p>(A) Binding dose curves with variable serum and curcuminoid concentrations in media containing FC...
<p><b>(A)</b><i>B</i>. <i>subtilis</i> AH75 strain was grown in LB media having spectinomycin antibi...
<p>MCF-7 cells were treated with either curcumin (10 µM) or Mitocur-1, 2, 3 (10 µM) respectively for...